全球智慧药丸市场规模、份额、趋势和成长分析报告（2026-2034年）

预计智慧药丸市场将从 2025 年的 26.6 亿美元成长到 2034 年的 73.7 亿美元，2026 年至 2034 年的复合年增长率为 11.97%。

随着数位医疗技术的进步，全球智慧药丸市场正蓬勃发展。智慧药丸是一种可吞服的电子设备，能够监测人体内部健康状况、拍摄消化道影像并将资料传送给医疗专业人员。这些设备正被越来越多地用于诊断消化系统疾病，为传统医疗程序提供了一种微创替代方案。

多种因素正在推动智慧药丸市场的成长。主要驱动因素包括胃肠道疾病盛行率的上升以及对微创诊断技术日益增长的需求。微型感测器、无线通讯系统和医学影像技术的进步正在提升智慧药丸的功能和准确性。此外，人们对远端患者监护和数位健康解决方案的日益关注也促使医疗专业人员采用这些创新诊断工具。

随着数位化和互联医疗技术在医疗保健系统中的日益普及，智慧药丸市场被认为具有极其广阔的发展前景。目前的研究和开发工作主要集中在提升口服型感测器的功能，例如药物传输监测和即时健康追踪。随着医疗专业人员寻求更有效率的诊断解决方案，智慧药丸有望在现代医疗保健中发挥日益重要的作用。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

• 市场谱系展望
• 渗透率和成长前景分析
• 价值链分析
• 法律规范
  • 标准与合规性
  • 监管影响分析
• 市场动态
  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场挑战
• 波特五力分析
• PESTLE分析

第四章：全球智慧药丸市场：按应用划分

• 市场分析、洞察与预测
• 胶囊内视镜
• 药物输送
• 生命征象监测

第五章：全球智慧药丸市场：依疾病分类

• 市场分析、洞察与预测
• 消化道出血
• 克隆氏症
• 小肠肿瘤
• 乳糜泻
• 遗传性息肉症候群
• 神经系统疾病
• 其他的

第六章：全球智慧药丸市场：依目标区域划分

• 市场分析、洞察与预测
• 食道
• 小肠
• 冒号
• 胃

第七章：全球智慧药丸市场：依最终用途划分

• 市场分析、洞察与预测
• 医院
• 门诊设施

第八章 全球智慧药丸市场：按地区划分

• 区域分析
• 北美市场分析、洞察与预测
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲市场分析、洞察与预测
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太市场分析、洞察与预测
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 东南亚
  • 其他亚太国家
• 拉丁美洲市场分析、洞察与预测
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲国家
• 中东和非洲市场分析、洞察与预测
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中东和非洲国家

第九章 竞争情势

• 最新趋势
• 公司分类
• 供应链和销售管道合作伙伴（根据现有资讯）
• 市场占有率和市场定位分析（基于现有资讯）
• 供应商情况（基于现有资讯）
• 策略规划

第十章：公司简介

• 主要公司的市占率分析
• 公司简介
  • Medtronic
  • Otsuka Holdings Co. Ltd
  • Olympus Corporation
  • CapsoCam Plus
  • Pentax Medical
  • JINSHAN Science & Technology（Group）Co. Ltd
  • Check-Cap Ltd
  • EtectRx
  • Intromedic
  • Shenzen Jifu Medical Technology Co. Ltd
  • BodyCapUSA

The Smart Pill Market size is expected to reach USD 7.37 Billion in 2034 from USD 2.66 Billion (2025) growing at a CAGR of 11.97% during 2026-2034.

The global smart pill market is gaining momentum as digital healthcare technologies continue to advance. Smart pills are ingestible electronic devices that can monitor internal health conditions, capture images of the gastrointestinal tract, and transmit data to healthcare providers. These devices are increasingly used for diagnostic purposes, particularly in gastrointestinal disorders, offering a less invasive alternative to traditional medical procedures.

Several factors are driving the growth of the smart pill market. Increasing prevalence of digestive diseases and the rising demand for minimally invasive diagnostic techniques are key contributors. Technological advancements in miniaturized sensors, wireless communication systems, and medical imaging technologies are improving the functionality and accuracy of smart pills. In addition, growing interest in remote patient monitoring and digital health solutions is encouraging healthcare providers to adopt these innovative diagnostic tools.

The future prospects of the smart pill market appear highly promising as healthcare systems increasingly adopt digital and connected medical technologies. Ongoing research and development efforts are focused on enhancing the capabilities of ingestible sensors, including drug delivery monitoring and real-time health tracking. As healthcare providers seek more efficient diagnostic solutions, smart pills are expected to play an increasingly important role in modern medical practice.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Application

• Capsule Endoscopy
• Drug Delivery
• Vital Sign Monitoring

By Disease Identification

• Occult GI Bleeding
• Crohn's Disease
• Small Bowel Tumors
• Celiac Disease
• Inherited Polyposis Syndromes
• Neurological Disorders
• Others

By Target Area

• Esophagus
• Small Intestine
• Large Intestine
• Stomach

By End-use

• Hospitals
• Outpatient Facilities

COMPANIES PROFILED

• Medtronic, Otsuka Holdings Co Ltd, Olympus Corporation, CapsoCam Plus, Pentax Medical, JINSHAN Science Technology Group Co Ltd, CheckCap Ltd, etectRx, Intromedic, Shenzen Jifu Medical Technology Co Ltd, BodyCapUSA
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL SMART PILL MARKET: BY APPLICATION 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Application
• 4.2. Capsule Endoscopy Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Drug Delivery Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Vital Sign Monitoring Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL SMART PILL MARKET: BY DISEASE IDENTIFICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Disease Identification
• 5.2. Occult GI Bleeding Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Crohn's Disease Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Small Bowel Tumors Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Celiac Disease Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Inherited Polyposis Syndromes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.7. Neurological Disorders Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.8. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL SMART PILL MARKET: BY TARGET AREA 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Target Area
• 6.2. Esophagus Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Small Intestine Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Large Intestine Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Stomach Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL SMART PILL MARKET: BY END-USE 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast End-use
• 7.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Outpatient Facilities Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL SMART PILL MARKET: BY REGION 2022-2034(USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Application
  • 8.2.2 By Disease Identification
  • 8.2.3 By Target Area
  • 8.2.4 By End-use
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Application
  • 8.3.2 By Disease Identification
  • 8.3.3 By Target Area
  • 8.3.4 By End-use
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Application
  • 8.4.2 By Disease Identification
  • 8.4.3 By Target Area
  • 8.4.4 By End-use
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Application
  • 8.5.2 By Disease Identification
  • 8.5.3 By Target Area
  • 8.5.4 By End-use
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 South East Asia
  • 8.5.10 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Application
  • 8.6.2 By Disease Identification
  • 8.6.3 By Target Area
  • 8.6.4 By End-use
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL SMART PILL INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 Medtronic
  • 10.2.2 Otsuka Holdings Co. Ltd
  • 10.2.3 Olympus Corporation
  • 10.2.4 CapsoCam Plus
  • 10.2.5 Pentax Medical
  • 10.2.6 JINSHAN Science & Technology (Group) Co. Ltd
  • 10.2.7 Check-Cap Ltd
  • 10.2.8 EtectRx
  • 10.2.9 Intromedic
  • 10.2.10 Shenzen Jifu Medical Technology Co. Ltd
  • 10.2.11 BodyCapUSA